UPDATE - UBS Downgraded Accretive Health (AH) to Neutral; Possibility Of More Issues Lurking
Tweet
Share
E-mailGet Alerts AH Hot Sheet
Price: $8.02 --0%
Rating Summary:
2 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
2 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
UPDATE - UBS downgraded Accretive Health (NYSE: AH) from Buy to Neutral. PT slashed from $29 to $11.
Analyst, Stephen Shankman, said, "Despite the big selloff in AH shares related to the Minnesota AG investigation, we believe there is potential for more negatives around the corner. In our view, large uncertainty exists around the impact of the investigation on existing customers and the pipeline, and possible EMTALA violations are very concerning. Other risks include more state regulators taking a closer look at AH, 2012 guidance update on May 9, and the 2012 Ascension contract renewal. As such, we are no longer comfortable recommending AH shares and move to a Neutral."
FY12 EPS estimate cut from $0.60 to $0.53 and FY13 from $0.88 to $0.73.
To see more ratings on AH, Click Here
Analyst, Stephen Shankman, said, "Despite the big selloff in AH shares related to the Minnesota AG investigation, we believe there is potential for more negatives around the corner. In our view, large uncertainty exists around the impact of the investigation on existing customers and the pipeline, and possible EMTALA violations are very concerning. Other risks include more state regulators taking a closer look at AH, 2012 guidance update on May 9, and the 2012 Ascension contract renewal. As such, we are no longer comfortable recommending AH shares and move to a Neutral."
FY12 EPS estimate cut from $0.60 to $0.53 and FY13 from $0.88 to $0.73.
To see more ratings on AH, Click Here
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Walmart (WMT) PT Lowered to $125 at JPMorgan, Overweight Rating Maintained as 'Short Case Feels Greedy'
- Ferrovial SA (FER:SM) (FRRVF) Reiterated at Buy by UBS on Winning Bid For Tennessee Project
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change, DowngradesRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
